Evidence map›Paper›PMID 39570180›Full record

ArticleArquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery2024

ADENOCARCINOMA AND DYSPLASIA IN BARRETT ESOPHAGUS: CRITICAL ANALYSIS OF RISK FACTORS AND SURVEILLANCE PROTOCOLS.

Eduardo Gallon, Sérgio Szachnowicz, André Fonseca Duarte, Francisco Tustumi, Rubens Antonio Aissar Sallum, Paulo Herman, Ulysses Ribeiro Junior

Abstract read
In one paragraph

Article in Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eduardo GallonUniversidade de São Paulo, Faculty of Medicine, Department of Gastroenterology - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0001-9764-9786
Sérgio SzachnowiczUniversidade de São Paulo, Faculty of Medicine, Department of Gastroenterology - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0002-6238-3532
André Fonseca DuarteUniversidade de São Paulo, Faculty of Medicine, Department of Gastroenterology - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0002-3332-0567
Francisco TustumiUniversidade de São Paulo, Faculty of Medicine, Department of Gastroenterology - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0001-6695-0496
Rubens Antonio Aissar SallumUniversidade de São Paulo, Faculty of Medicine, Department of Gastroenterology - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0003-1823-0042
Paulo HermanUniversidade de São Paulo, Faculty of Medicine, Department of Gastroenterology - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0003-2859-5846
Ulysses Ribeiro JuniorUniversidade de São Paulo, Faculty of Medicine, Department of Gastroenterology - São Paulo (SP), Brazil.ORCID http://orcid.org/0000-0003-1711-7347

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentification of epidemiological risk factors in Barrett esophagus resulting in dysplasia and adenocarcinoma and its impact on prevention and early detection.

aimsTo evaluate epidemiological risk factors involved in the development of dysplasia and esophageal adenocarcinoma from Barrett esophagus in a specific population. To critically analyze the surveillance period, aiming to individualize follow-up time according to identified risks.

methodsA retrospective case-control study was carried out at a tertiary center involving patients diagnosed and followed up for Barrett esophagus. Patients who developed esophageal adenocarcinoma and/or dysplasia were compared to those who did not, considering variables such as gender, age, smoking status, body mass index, ethnicity, and Barrett esophagus extension. Logistic regression was performed to measure the odds ratio for risk factors associated with the outcome of adenocarcinoma and dysplasia. The presence of epidemiological risk factors in this population was correlated with the time taken to develop esophageal adenocarcinoma from metaplasia.

resultsA statistically significant difference was observed in smoking status, race, gender, Barrett esophagus extension, and age between the group with esophageal adenocarcinoma and the group without it. Smokers and former smokers had a 4.309 times higher risk of developing esophageal adenocarcinoma, and each additional centimeter of Barrett esophagus increased the risk by 1.193 times. In the dysplasia group, smoking status, Barrett esophagus extension, and age were statistically significant factors; each additional centimeter of Barrett esophagus extension increased the risk of dysplasia by 1.128 times, and each additional year of age increased the risk by 1.023 times. Patients without risk factors did not develop esophageal adenocarcinoma within 12 months, even with prior dysplasia.

conclusionsThe study confirmed a higher risk of developing dysplasia and esophageal adenocarcinoma in specific epidemiological groups, allowing for more cost-effective monitorization for patients with Barrett esophagus.

Indexed as

AdenocarcinomaBarrett EsophagusEsophageal NeoplasmsAdultAgedCase-Control StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk Factors

Identifiers

PMID39570180
PMCPMC11571873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.